BSX
Boston Scientific Corp
Price:  
90.42 
USD
Volume:  
4,000,786.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BSX EV/EBITDA

-48.7%
Upside

As of 2024-12-13, the EV/EBITDA ratio of Boston Scientific Corp (BSX) is 33.99. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BSX's latest enterprise value is 141,646.70 mil USD. BSX's TTM EBITDA according to its financial statements is 4,167.00 mil USD. Dividing these 2 quantities gives us the above BSX EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 14.1x - 20.9x 18.4x
Forward P/E multiples 20.8x - 21.7x 21.2x
Fair Price 34.18 - 53.46 46.42
Upside -62.2% - -40.9% -48.7%
90.42 USD
Stock Price
46.42 USD
Fair Price

BSX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-13 34.01
2024-12-12 33.99
2024-12-11 34.04
2024-12-10 33.91
2024-12-09 33.39
2024-12-06 33.87
2024-12-05 34.03
2024-12-04 34.14
2024-12-03 34.01
2024-12-02 34.00
2024-11-29 34.08
2024-11-27 34.11
2024-11-26 33.92
2024-11-25 33.58
2024-11-22 33.84
2024-11-21 34.37
2024-11-20 33.90
2024-11-19 33.96
2024-11-18 34.00
2024-11-15 32.78
2024-11-14 32.99
2024-11-13 33.41
2024-11-12 33.39
2024-11-11 33.31
2024-11-08 33.22
2024-11-07 32.74
2024-11-06 32.58
2024-11-05 32.27
2024-11-04 31.98
2024-11-01 31.59
2024-10-31 31.73
2024-10-30 31.72
2024-10-29 31.92
2024-10-28 31.99
2024-10-25 31.98
2024-10-24 32.11
2024-10-23 32.94
2024-10-22 33.14
2024-10-21 33.15
2024-10-18 33.16
2024-10-17 32.58
2024-10-16 32.78
2024-10-15 32.70
2024-10-14 32.98
2024-10-11 32.82
2024-10-10 32.50
2024-10-09 32.68
2024-10-08 32.37
2024-10-07 31.87
2024-10-04 31.91